阿尔茨海默病的粉样β会影响人类神经元的膜结构和机械特性
Sophie Asnacios1,2, Galya Staneva3, Gabriel Thon1,4
1Laboratory Matière et Systèmes Complexes UMR 7057 CNRS, University Paris Cité, Paris, France.
Journal of Alzheimer's disease : JAD
|December 9, 2025
概括
阿尔茨海默氏病 (AD) 涉及粉样β (Aβ) 寡合体,影响神经原生细胞 (NPC) 机制. 暴露于Aβ寡合体会使NPC变硬并增加膜脂质秩序,可能会影响神经发生.
科学领域:
- 神经科学是一个神经科学.
- 生物物理学的生物物理.
- 细胞生物学 细胞生物学
背景情况:
- 阿尔茨海默氏病 (AD) 的发病包括粉样β (Aβ) 的过度生产,可溶性Aβ寡合体被确定为关键的有毒物种.
- 神经发生和神经可塑性在阿尔茨海默病中受损,但潜在的机制仍然不清楚.
- 细胞变形性对于神经发生和神经可塑性至关重要.
研究的目的:
- 研究Aβ寡合体对人类神经原生细胞 (h-NPCs) 机械性质的影响.
- 探索Aβ寡合体暴露,h-NPC机械变化和膜结构之间的关系.
主要方法:
- 使用来自h-ESCs的人类神经原生细胞 (h-NPCs).
- 微板类风湿学和频率分析测量了粘弹性模块.
- 与焦点显微镜评估的血膜脂质顺序.
- 使用提奥夫拉T,DLS和TEM进行了Aβ42聚合的特征.
主要成果:
- h-NPCs主要表现出具有低弹性模块 (∼200 Pa) 的弹性行为.
- Aβ42寡合体显著增加了h-NPC的弹性和粘性模块 (增加了3倍),表明细胞变硬.
- 这种由Aβ42诱导的硬化与血膜脂质顺序的增加相关.
结论:
- Aβ42寡合体改变神经前细胞的机械特性和膜结构.
- 这些Aβ42诱导的h-NPC变形性和膜变化可能会影响神经分化.
- 这些发现表明,Aβ介导的机械变化在阿尔茨海默病中观察到的神经发生缺陷中可能发挥作用.
相关概念视频
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Amyloid Fibrils
6.2K
6.2K
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K


